Donald Joseph
Consigliere Generale presso ACER THERAPEUTICS INC.
Posizioni attive di Donald Joseph
Società | Posizione | Inizio | Fine |
---|---|---|---|
ACER THERAPEUTICS INC. | Consigliere Generale | 01/04/2018 | - |
Segretario Aziendale | 01/04/2018 | - | |
Bio Ventures for Global Health | Direttore/Membro del Consiglio | 06/04/2010 | - |
Segretario Aziendale | 06/04/2010 | - | |
Presidente | 24/06/2013 | - | |
Direttore operativo | 08/04/2010 | 24/06/2013 | |
Presidente | 06/04/2010 | 24/06/2013 |
Storia della carriera di Donald Joseph
Precedenti posizioni note di Donald Joseph
Società | Posizione | Inizio | Fine |
---|---|---|---|
ACHIEVE LIFE SCIENCES, INC. | Direttore/Membro del Consiglio | 01/08/2017 | 07/06/2023 |
Independent Dir/Board Member | 01/08/2017 | 07/06/2023 | |
HUMANIGEN, INC. | Consigliere Generale | 17/06/2013 | 01/11/2015 |
Segretario Aziendale | 17/06/2013 | 01/11/2015 | |
Renovis, Inc.
Renovis, Inc. Pharmaceuticals: MajorHealth Technology Renovis, Inc. develops pharmaceutical products. The company discovers, develops, and commercializes novel therapeutics for neurological and inflammatory diseases. It is headquartered in San Francisco, CA | Consigliere Generale | - | - |
Segretario Aziendale | - | - | |
Abgenix, Inc.
Abgenix, Inc. BiotechnologyHealth Technology Abgenix, Inc. developed therapeutic products. It focused on the discovery, development and manufacturing of therapeutic antibodies. The firm's antibody development platform included manufacturing fully human antibody product candidates to a variety of disease targets. The company was founded by R. Scott Greer in 1996 and was headquartered in Fremont, CA. | Consigliere Generale | - | - |
Segretario Aziendale | - | - | |
Baker & McKenzie LLP (New York)
Baker & McKenzie LLP (New York) Miscellaneous Commercial ServicesCommercial Services Baker & McKenzie LLP (New York) provides legal services. Its practice offers antitrust and competition, banking and finance, capital markets, compliance and investigations, dispute resolution, employment and compensation, environment and climate change, information technology and communications, intellectual property, international commercial and trade, mergers and acquisitions, private equity, real estate, restructuring and insolvency, and tax. The company was founded on July 6, 2004 and is headquartered in New York, NY. | Corporate Officer/Principal | - | - |
PATH Drug Solutions | Direttore operativo | - | - |
Formazione di Donald Joseph
The University of Texas School of Law | Graduate Degree |
Statistiche
Distribuzione geografica
Stati Uniti | 9 |
Canada | 2 |
Posizioni
Corporate Secretary | 5 |
General Counsel | 4 |
Director/Board Member | 2 |
Settori
Health Technology | 6 |
Commercial Services | 3 |
Consumer Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 2 |
---|---|
HUMANIGEN, INC. | Health Technology |
ACHIEVE LIFE SCIENCES, INC. | Health Technology |
Aziende private | 6 |
---|---|
Bio Ventures for Global Health | |
PATH Drug Solutions | Commercial Services |
Baker & McKenzie LLP (New York)
Baker & McKenzie LLP (New York) Miscellaneous Commercial ServicesCommercial Services Baker & McKenzie LLP (New York) provides legal services. Its practice offers antitrust and competition, banking and finance, capital markets, compliance and investigations, dispute resolution, employment and compensation, environment and climate change, information technology and communications, intellectual property, international commercial and trade, mergers and acquisitions, private equity, real estate, restructuring and insolvency, and tax. The company was founded on July 6, 2004 and is headquartered in New York, NY. | Commercial Services |
Abgenix, Inc.
Abgenix, Inc. BiotechnologyHealth Technology Abgenix, Inc. developed therapeutic products. It focused on the discovery, development and manufacturing of therapeutic antibodies. The firm's antibody development platform included manufacturing fully human antibody product candidates to a variety of disease targets. The company was founded by R. Scott Greer in 1996 and was headquartered in Fremont, CA. | Health Technology |
Acer Therapeutics, Inc.
Acer Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Acer Therapeutics, Inc. is a pharmaceutical company, which engages in the acquisition, development, and commercialization of therapies for medical needs. Its product pipeline includes Olpruva, Edsivo, and ACER-801. Olpruva is used for the treatment of urea cycle disorders. Edsivo is a type of celiprolol used in treating Vascular Ehlers-Danlos syndrome. ACER-001 treats menopausal related Vasomotor symptoms. The company was founded by Chris Schelling on March 15, 1991 and is headquartered in Newton, MA. | Health Technology |
Renovis, Inc.
Renovis, Inc. Pharmaceuticals: MajorHealth Technology Renovis, Inc. develops pharmaceutical products. The company discovers, develops, and commercializes novel therapeutics for neurological and inflammatory diseases. It is headquartered in San Francisco, CA | Health Technology |
- Borsa valori
- Insiders
- Donald Joseph
- Esperienza